Drug induced QT prolongation and torsades de pointes

尖端扭转 延长 QT间期 医学 药品 长QT综合征 内科学 心脏病学 药理学
作者
Y. G. Yap
出处
期刊:British heart journal [BMJ]
卷期号:89 (11): 1363-1372 被引量:909
标识
DOI:10.1136/heart.89.11.1363
摘要

n 1966, Francois Dessertenne described a specific electrocardiographic form of polymorphic ventricular tachycardia, which he termed ''torsades de pointes'' (TdP).w1 w2 The word ''torsades'' refers to an ornamental motif imitating twisted hairs or threads as seen on classical architectural columns, and ''pointes'' referred to points or peaks.w1 w2 In the seminal article, Dessertenne made no attempt to suggest the mechanism of TdP and, until recently, there has been considerable conjecture as to the pathophysiology of this arrhythmia. CAUSES OF TORSADES DE POINTES cSince the original work by Dessertenne, it has been well recognised that many conditions may cause prolonged or abnormal repolarisation (that is, QT interval prolongation and/or abnormal T or T/U wave morphology), which is associated with TdP.If TdP is rapid or prolonged, it can lead to ventricular fibrillation and sudden cardiac death (fig 1).Essentially, TdP may be caused by either congenital or acquired long QT syndrome (LQTS).In recent years, there has been considerable renewed interest in the assessment and understanding of ventricular repolarisation and TdP.There are several reasons for this.Firstly, the cloning of cardiac ion channels has improved the understanding of the role of ionic channels in mediating cardiac repolarisation, the pathophysiological mechanism of LQTS (congenital and acquired forms), and the pathogenesis of TdP.Secondly, modern molecular techniques have unravelled the mutations in genes encoding cardiac ion channels that cause long QT syndrome, although the genetic defects in about 50% of patients are still unknown.Thirdly, there has been considerable enthusiasm for the development and use of class III antiarrhythmic drugs, which prolong repolarisation and cardiac refractoriness.Unfortunately, drugs that alter repolarisation have now been recognised to increase the propensity for TdP.Finally, an increasing number of drugs, especially non-cardiac drugs, have been recognised to delay cardiac repolarisation and to share the ability with class III antiarrhythmics to cause TdP occasionally.Many of the drugs that were initially known to prolong the QT interval were antiarrhythmics, and quinidine was the most commonly implicated agent.Surprisingly, many non-cardiac drugs have also been reported to cause QT prolongation and/or TdP recently.In a survey in both the UK and Italy, non-cardiac drugs that have pro-arrhythmic potential (that is, have an official warning on QT prolongation or TdP, or with published data on QT prolongation, ventricular tachycardia, or class III effect) alone represented 3% and 2% of total prescriptions in both countries, respectively. 1 The danger of drug induced pro-arrhythmia is therefore serious.This issue has been identified as a considerable public health problem and has attracted attention from the drug regulatory authorities.The exact incidence of drug induced TdP in the general population is largely unknown.Most of our understandings of the incidence, risk factors, and drug interaction of pro-arrhythmic drugs are derived form epidemiological studies, anecdotal case reports, clinical studies during drug development, and post-marketing surveillance.The awareness of drug induced TdP in the last few years has resulted in an increase in the number of spontaneous reports.Nevertheless, the absolute total number remains very low, although it has been suggested that the system of spontaneous reporting under-reports the true incidence of serious adverse reactions by a factor of at least 10. 2 Between 1983 and December 1999, 761 cases of TdP, of which 34 were fatal, were reported to the World Health Organization Drug Monitoring Centre by the member states. 3 The WHO data provide an insight into the incidence of TdP on the most commonly reported pro-arrhythmic drugs 3 (table 1).However, such a reporting system is undermined by the widely variable content and clinical information between different countries and sources.It is also compounded by various factors such as the patient's underlying disease, whether the adverse drug reaction is well known or has not been previously described, and the amount of attention paid by the medical community on a specific adverse drug reaction.In this article, we will review the risk of drug induced QT prolongation and/or TdP.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
青梧完成签到,获得积分10
刚刚
裴瑞志完成签到,获得积分10
刚刚
归宁发布了新的文献求助10
1秒前
Sherlock完成签到,获得积分10
3秒前
荔枝味完成签到,获得积分20
3秒前
感动如音完成签到 ,获得积分10
4秒前
不想看文献完成签到 ,获得积分10
4秒前
Maestro_S的应助被晚风采纳,获得10
4秒前
Lczhou完成签到,获得积分10
4秒前
6秒前
无情愫的应助被WM采纳,获得10
6秒前
DW的应助被zhouqian采纳,获得10
6秒前
zhenzhen完成签到,获得积分10
7秒前
lilili发布了新的文献求助10
7秒前
一行发布了新的文献求助10
7秒前
Nole的应助被15735802374采纳,获得10
8秒前
生性不爱说话完成签到,获得积分10
8秒前
8秒前
9秒前
dumeng发布了新的文献求助20
12秒前
花海发布了新的文献求助10
12秒前
12秒前
12秒前
13秒前
13秒前
乐空思的应助被zcl采纳,获得20
13秒前
SciGPT的应助被谨慎的秋烟采纳,获得30
14秒前
123发布了新的文献求助10
16秒前
脑洞疼的应助被包语梦采纳,获得10
17秒前
molihuakai的应助被Zzz采纳,获得10
17秒前
17秒前
ghw发布了新的文献求助10
17秒前
19秒前
陈婉鸿完成签到,获得积分10
19秒前
20秒前
wanci的应助被Monarch采纳,获得10
20秒前
打打的应助被晴朗采纳,获得10
21秒前
东都哈士奇完成签到,获得积分10
21秒前
22秒前
22秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8172327
求助须知:如何正确求助?哪些是违规求助? 9564990
关于积分的说明 21777687
捐赠科研通 7763968
什么是DOI,文献DOI怎么找? 3431223
关于科研通互助平台的介绍 2555098
邀请新用户注册赠送积分活动 2476246